Training | 2016.03.19
ProMIS Neurosciences Announces Identification of a Third Novel Therapeutic Target for Alzheimer’s Disease
Novel target is third in a series of potential targets on strains of misfolded Amyloid beta, implicated in the development and progression of Alzheimer’s
(PRWeb March 18, 2016)
Read the full story at http://www.prweb.com/releases/2016/03/prweb13276024.htm
For more information, please visit
http://www.prweb.com/releases/2016/03/prweb13276024.htm
